Abraxis’ billionaire chief is adding to his blockbuster bank account

Dr. Patrick Soon-Shiong has been involved in his share of controversies over the years, but none of them have done anything to reduce his net worth. Already worth $4 billion following the sale of APP Pharmaceuticals, the son of Chinese refugees is getting a big bump from the $2.9 billion sale of Abraxis to Celgene. He owns 82 percent of the company, which is primarily devoted to selling the cancer drug Abraxane while working on new approvals for additional indications. "He's done some things...